Market Cap 1.27B
Revenue (ttm) 388.54M
Net Income (ttm) -13.36M
EPS (ttm) N/A
PE Ratio 119.08
Forward PE 110.26
Profit Margin -3.44%
Debt to Equity Ratio 1.07
Volume 549,600
Avg Vol 428,802
Day's Range N/A - N/A
Shares Out 42.70M
Stochastic %K 84%
Beta 1.62
Analysts Strong Sell
Price Target $32.71

Company Profile

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac and preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts, including E-vita Open NEO, E-vita Open Plus, ascyrus medical dissection stent hybrid prosthesis, E-vita THOR...

Industry: Medical Devices
Sector: Healthcare
Phone: 770 419 3355
Address:
1655 Roberts Boulevard NW, Kennesaw, United States
JarvisFlow
JarvisFlow Jun. 17 at 11:30 AM
Canaccord Genuity updates rating for Artivion ( $AORT ) to Buy, target set at 35.
0 · Reply
Estimize
Estimize May. 8 at 3:13 PM
Wall St is expecting 0.12 EPS for $AORT Q2 [Reporting 07/31 AMC] http://www.estimize.com/intro/aort?chart=historical&metric_name=eps&utm_co
0 · Reply
Wigglyick
Wigglyick May. 7 at 4:08 PM
$AORT hidden gem ? Only 300 watchers on ST. Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. Pop on ER, increasing sales.
1 · Reply
PenkeTrading
PenkeTrading May. 7 at 3:16 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Artivion Inc. Is that bullish or bearish? $AORT #Artivion #RsiOverbought #NYSE
0 · Reply
MaverikIT
MaverikIT May. 6 at 4:16 PM
0 · Reply
MaverikIT
MaverikIT May. 6 at 3:11 PM
$AORT +2.32 - raising FY25 sale$
0 · Reply
JarvisFlow
JarvisFlow May. 6 at 11:00 AM
Needham updates rating for Artivion ( $AORT ) to Buy, target set at 32.
0 · Reply
Estimize
Estimize May. 6 at 12:27 AM
$AORT reported 0.06 EPS and 98.98 revenue for Q1. http://www.estimize.com/intro/aort?chart=historical&metric_name=eps&utm_content=AORT&utm_
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine May. 5 at 11:06 AM
$AORT's NEXUS TRIOMPHE trial shows a 63% reduction in major adverse events at 30 days - a critical milestone for their aortic arch device. With PMA submission planned after 1-year data, this could be the catalyst they need. CEO Mackin's optimism suggests confidence in long-term outcomes. High-risk patients getting safer options = market expansion. https://www.prnewswire.com/news-releases/artivion-announces-presentation-of-new-clinical-data-from-nexus-triomphe-ide-trial-at-the-105th-american-association-for-thoracic-surgery-aats-annual-meeting-302445689.html
0 · Reply
swingingtech
swingingtech Apr. 24 at 2:21 PM
$IJR $TRUP $BFS $AORT https://wallstreetwaves.com/analysts-predict-34-growth-potential-for-ijr/
1 · Reply
Latest News on AORT
Artivion to Participate in Upcoming Investor Conferences

Jun 3, 2025, 4:10 PM EDT - 17 days ago

Artivion to Participate in Upcoming Investor Conferences


Artivion, Inc. (AORT) Q1 2025 Earnings Call Transcript

May 5, 2025, 10:37 PM EDT - 6 weeks ago

Artivion, Inc. (AORT) Q1 2025 Earnings Call Transcript


Artivion Reports First Quarter 2025 Financial Results

May 5, 2025, 4:05 PM EDT - 6 weeks ago

Artivion Reports First Quarter 2025 Financial Results


Artivion, Inc. (AORT) Q4 2024 Earnings Call Transcript

Feb 24, 2025, 11:00 PM EST - 4 months ago

Artivion, Inc. (AORT) Q4 2024 Earnings Call Transcript


Artivion, Inc. (AORT) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 12:02 PM EST - 7 months ago

Artivion, Inc. (AORT) Q3 2024 Earnings Call Transcript


Artivion Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 4:05 PM EST - 8 months ago

Artivion Reports Third Quarter 2024 Financial Results


Artivion, Inc. (AORT) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 2:45 PM EDT - 11 months ago

Artivion, Inc. (AORT) Q2 2024 Earnings Call Transcript


Artivion Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 4:05 PM EDT - 11 months ago

Artivion Reports Second Quarter 2024 Financial Results


Artivion Amends Agreements with Endospan

Jul 1, 2024, 4:05 PM EDT - 1 year ago

Artivion Amends Agreements with Endospan


Data-Driven Growth Fuels More Upside For Overlooked Artivion

Jun 21, 2024, 5:01 PM EDT - 1 year ago

Data-Driven Growth Fuels More Upside For Overlooked Artivion


Artivion, Inc. (AORT) Q1 2024 Earnings Call Transcript

May 6, 2024, 10:47 PM EDT - 1 year ago

Artivion, Inc. (AORT) Q1 2024 Earnings Call Transcript


Artivion Reports First Quarter 2024 Financial Results

May 6, 2024, 4:05 PM EDT - 1 year ago

Artivion Reports First Quarter 2024 Financial Results


Artivion, Inc. (AORT) Q4 2023 Earnings Call Transcript

Feb 15, 2024, 8:22 PM EST - 1 year ago

Artivion, Inc. (AORT) Q4 2023 Earnings Call Transcript


Artivion, Inc. (AORT) Q3 2023 Earnings Call Transcript

Nov 5, 2023, 1:51 AM EDT - 1 year ago

Artivion, Inc. (AORT) Q3 2023 Earnings Call Transcript


Artivion Reports Third Quarter 2023 Financial Results

Nov 2, 2023, 4:05 PM EDT - 1 year ago

Artivion Reports Third Quarter 2023 Financial Results


Artivion, Inc. (AORT) Q2 2023 Earnings Call Transcript

Aug 5, 2023, 1:28 PM EDT - 2 years ago

Artivion, Inc. (AORT) Q2 2023 Earnings Call Transcript


Artivion Reports Second Quarter 2023 Financial Results

Aug 3, 2023, 4:05 PM EDT - 2 years ago

Artivion Reports Second Quarter 2023 Financial Results


Artivion, Inc. (AORT) Q1 2023 Earnings Call Transcript

May 7, 2023, 11:49 AM EDT - 2 years ago

Artivion, Inc. (AORT) Q1 2023 Earnings Call Transcript


JarvisFlow
JarvisFlow Jun. 17 at 11:30 AM
Canaccord Genuity updates rating for Artivion ( $AORT ) to Buy, target set at 35.
0 · Reply
Estimize
Estimize May. 8 at 3:13 PM
Wall St is expecting 0.12 EPS for $AORT Q2 [Reporting 07/31 AMC] http://www.estimize.com/intro/aort?chart=historical&metric_name=eps&utm_co
0 · Reply
Wigglyick
Wigglyick May. 7 at 4:08 PM
$AORT hidden gem ? Only 300 watchers on ST. Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. Pop on ER, increasing sales.
1 · Reply
PenkeTrading
PenkeTrading May. 7 at 3:16 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Artivion Inc. Is that bullish or bearish? $AORT #Artivion #RsiOverbought #NYSE
0 · Reply
MaverikIT
MaverikIT May. 6 at 4:16 PM
0 · Reply
MaverikIT
MaverikIT May. 6 at 3:11 PM
$AORT +2.32 - raising FY25 sale$
0 · Reply
JarvisFlow
JarvisFlow May. 6 at 11:00 AM
Needham updates rating for Artivion ( $AORT ) to Buy, target set at 32.
0 · Reply
Estimize
Estimize May. 6 at 12:27 AM
$AORT reported 0.06 EPS and 98.98 revenue for Q1. http://www.estimize.com/intro/aort?chart=historical&metric_name=eps&utm_content=AORT&utm_
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine May. 5 at 11:06 AM
$AORT's NEXUS TRIOMPHE trial shows a 63% reduction in major adverse events at 30 days - a critical milestone for their aortic arch device. With PMA submission planned after 1-year data, this could be the catalyst they need. CEO Mackin's optimism suggests confidence in long-term outcomes. High-risk patients getting safer options = market expansion. https://www.prnewswire.com/news-releases/artivion-announces-presentation-of-new-clinical-data-from-nexus-triomphe-ide-trial-at-the-105th-american-association-for-thoracic-surgery-aats-annual-meeting-302445689.html
0 · Reply
swingingtech
swingingtech Apr. 24 at 2:21 PM
$IJR $TRUP $BFS $AORT https://wallstreetwaves.com/analysts-predict-34-growth-potential-for-ijr/
1 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 28 at 12:03 AM
$AORT Digging the FDA approval for AMDS. Huge potential for growth in aortic disease market. Watching closely for Q1 performance and global expansion momentum. Might start building a position. essential takeaways from recent developments: https://beyondspx.com/article/artivion-inc-nyse-aort-navigating-aortic-disease-solutions-with-innovation-and-expertise
0 · Reply
ajmrtxl
ajmrtxl Mar. 17 at 2:42 PM
$AORT's latest data on SqueezeFinder
0 · Reply
d_risk
d_risk Mar. 1 at 9:49 PM
$AORT - Artivion Inc. Common Stock - 10K - Updated Risk Factors AORT's 2025 risk factors emphasize new compliance obligations, geopolitical tensions, supply chain vulnerabilities, regulatory challenges, cybersecurity threats, and financial restrictions, with a focus on innovation, market expansion, and strategic execution amid global instability. #Risk https://d-risk.ai/AORT/10-K/2025-02-28
0 · Reply
LewisDaKat
LewisDaKat Feb. 26 at 1:55 AM
$AORT News out (AORT) Trading Advice https://marketwirenews.com/news-releases/-aort-trading-advice-7767459604930493.html $AORT
0 · Reply
JarvisFlow
JarvisFlow Feb. 25 at 4:21 PM
Citizens Capital Markets updates rating for Artivion ($AORT) to Market Outperform, target set at 33.
0 · Reply
swingingtech
swingingtech Feb. 25 at 4:08 PM
$AORT https://wallstreetwaves.com/aort-falls-below-critical-moving-average-threshold/
0 · Reply
Estimize
Estimize Feb. 25 at 11:03 AM
$AORT reported 0.00 EPS and 97.31 revenue for Q4. http://www.estimize.com/intro/aort?chart=historical&metric_name=eps&utm_content=AORT&utm_
0 · Reply
trendx
trendx Feb. 6 at 2:05 PM
CURRENTLY WE ARE STUDYING THE CHART OF 1. $AORT 2. $GOOGL 3. $RDW
0 · Reply
WAJeff
WAJeff Jan. 22 at 7:36 PM
Didn’t change much today, largely waiting with bids for what I want. I did make a small buy of $SNEX and $AORT, added more $ABCL, $CLBT, $NBIS (latter may have just entered top 75)
1 · Reply
G101SPM
G101SPM Dec. 13 at 6:15 PM
#INSIDERS $NOTV Chief Operating Officer bought 30,000 shares at $4.75 worth approximately $143K. $PLAY interim Chief Executive Officer bought 37,735 shares worth approximately $961K. $ALK Executive Vice President - CFO and Executive Vice President - People sold 8,700 shares combined worth approximately $553K. $AORT SVP, General Counsel sold 8,070 shares at $30.00 - $30.25 worth approximately $243K. $TSSI Senior Vice President sold 72,925 shares at $9.05 - $9.85 worth approximately $691K.
0 · Reply
Aswecan
Aswecan Dec. 11 at 8:31 AM
AGCO ( $AGCO) Price Target Raised to $100.00 Needham & Company LLC Reaffirms “Buy” Rating for Artivion ( $AORT) Vontobel Holding Makes New Investment in Wimi Hologram Cloud Inc. ( $WIMI )
0 · Reply